Table 1. Basic characteristics of involved individuals in the serum study.
Health patients /BPH (N = 51) | PCa (N = 98) | P value | |
---|---|---|---|
Age | 67.63 ± 5.03 | 67.83 ± 4.82 | 0.81 |
PSA | 2.18 ± 2.42 | 35.94 ± 99.31 | 0.001** |
fPSA /PSA | 0.40 ± 0.49 | 0.07 ± 0.07 | < 0.001** |
BMI | 22.07 ± 1.18 | 22.05 ± 1.11 | 0.94 |
BG | 5.43 ± 0.32 | 5.27 ± 0.47 | 0.01* |
SP | 125.63 ± 13.26 | 127.51 ± 12.78 | 0.40 |
DP | 79.02 ± 10.19 | 77.95 ± 10.11 | 0.54 |
CHO | 3.98 ± 0.77 | 4.71 ± 0.92 | 0.01* |
TG | 1.44 ± 0.79 | 1.57 ± 0.73 | 0.63 |
LDL | 2.59 ± 0.63 | 3.18 ± 0.63 | 0.01* |
HDL | 1.16 ± 0.31 | 1.12 ± 0.43 | 0.73 |
FFA | 0.38 ± 0.15 | 0.35 ± 0.13 | 0.46 |
OT | 31.31 ± 13.34 | 37.53 ± 9.18 | 0.005** |